The mechanistic study revealed that M2 microglial EVs attenuated BBB disruption in the acute stage of cerebral ischemia by delivering miR-23a-5p, which targeted TNF and regulated MMP3 and NFκB p65 expression. The gene discussed is MMP3; the disease is brain ischemia.